Bone Biologics (BBLG)
(Real Time Quote from BATS)
$1.22 USD
-0.10 (-7.58%)
Updated Nov 12, 2024 02:53 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.60 |
EPS Last Quarter | -0.67 |
Last EPS Surprise | 51.80% |
ABR | NA |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.17 |
Next Year | -2.19 |
EPS (TTM) | -49.63 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | NA | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.60 | -0.59 | -3.17 | -2.19 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.60 | -0.59 | -3.17 | -2.19 |
High Estimate | -0.60 | -0.59 | -3.17 | -2.19 |
Low Estimate | -0.60 | -0.59 | -3.17 | -2.19 |
Year ago EPS | -4.88 | NA | -34.01 | -3.17 |
Year over Year Growth Est. | 87.70% | NA | 90.68% | 30.91% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.60 | -0.59 | -3.17 | -2.19 |
7 Days Ago | -0.60 | -0.59 | -3.17 | -2.19 |
30 Days Ago | -0.60 | -0.59 | -3.17 | -2.19 |
60 Days Ago | -0.60 | -0.59 | -3.17 | -2.19 |
90 Days Ago | -0.60 | -0.59 | -3.17 | -2.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.60 | -0.59 | -3.17 | -2.19 |
Zacks Consensus Estimate | -0.60 | -0.59 | -3.17 | -2.19 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.67 | -1.31 | NA | -4.88 | NA |
Estimate | -1.39 | -7.60 | NA | -24.32 | NA |
Difference | 0.72 | 6.29 | NA | 19.44 | 8.82 |
Surprise | 51.80% | 82.76% | NA | 79.93% | 71.50% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more